We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




RF Ablation Shows Promise for Treating Breast Tumors

By HospiMedica staff writers
Posted on 09 Jan 2003
A small trial has found that radiofrequency (RF) ablation may treat some breast tumors without surgery and with little cosmetic harm. More...
The results were reported at the Breast Cancer Symposium in San Antonio (TX, USA).

In the trial, 30 women with early stage breast cancer who were already scheduled to have a mastectomy or lumpectomy agreed to have RF ablation of their tumor first. When their breast tissue was removed, researchers examined whether the tumors has been destroyed. In 28 of the women (93%), the tumors were completely eradicated when the lesion had been accurately targeted by ultrasound.

The M.D. Anderson Cancer Center (Houston, TX, USA) participated in the trial and will start a new 20-patient trial of the technique within several months. The women in this trial will receive only RF ablation and will be closely monitored for several years. Researchers say the tumors should be two centimeters or smaller in size, clearly identifiable by ultrasound, and not up against the skin or chest wall.

"Radiofrequency ablation is a nonsurgical lumpectomy that may be used to treat small invasive breast cancers in the future,” says Eva Singletary, M.D., a surgeon at M.D. Anderson who is pioneering use of the technique. "It has the potential to offer local control of cancer with an even better cosmetic result than lumpectomy.”





Related Links:
M.D. Anderson

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.